Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score

Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical da...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2012-07, Vol.64 (7), p.2366-2374
Hauptverfasser: Consolaro, Alessandro, Bracciolini, Giulia, Ruperto, Nicolino, Pistorio, Angela, Magni-Manzoni, Silvia, Malattia, Clara, Pederzoli, Silvia, Davì, Sergio, Martini, Alberto, Ravelli, Angelo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2374
container_issue 7
container_start_page 2366
container_title Arthritis & rheumatology (Hoboken, N.J.)
container_volume 64
creator Consolaro, Alessandro
Bracciolini, Giulia
Ruperto, Nicolino
Pistorio, Angela
Magni-Manzoni, Silvia
Malattia, Clara
Pederzoli, Silvia
Davì, Sergio
Martini, Alberto
Ravelli, Angelo
description Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity. Results With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values. Conclusion Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.
doi_str_mv 10.1002/art.34373
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022839874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3277941431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</originalsourceid><addsrcrecordid>eNp1kd1u1DAQhS0EokvhghdAlhASSE3rnzhOuKtaKD8VSKVQxI1lOxPW28QJtrew78RDYtjtVgJxZY39nTPHMwg9pGSfEsIOdEj7vOSS30IzKlhTEMrpbTQjhJQFFw3dQfdiXOSSccHvoh3GGKesrmfo5xkMLkY3-j08OO8G3ePWRdARsLbJXbm02sPat7myMCVtesBxNUxpHHBMOgF2Hi-WV-BdfnGtGyed5s7iHGoeXHLxOT6GLlv7r9jmCwhOY5P9Wzx6nOZwo95K_omAox0D3Ed3Ot1HeLA5d9HHly_Oj14Vp-9PXh8dnha2FBUvKqNNzY0UUlMrTdUZQkQp2rqrDLTUdBYsa0Rjm7Yuy5ZpRqvaGs4pKamsDd9FT9e-Uxi_LSEmlWdkoe-1h3EZFSWM1bypZZnRx3-hi3EZfE6nqKCSUllVNFPP1pQNY4wBOjWFPOqwylbq9wpV_rr6s8LMPto4Ls0A7Za83lkGnmwAHa3uu6C9dfGGq6iURJDMHay573m2q_93VIdn59eti7XCxQQ_tgodLlUluRTq4t2J-nLxtv7w5vMndcx_AdzgxVM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517117661</pqid></control><display><type>article</type><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo</creator><creatorcontrib>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo ; Paediatric Rheumatology International Trials Organization ; for the Paediatric Rheumatology International Trials Organization</creatorcontrib><description>Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity. Results With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values. Conclusion Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</description><identifier>ISSN: 0004-3591</identifier><identifier>ISSN: 2326-5191</identifier><identifier>EISSN: 1529-0131</identifier><identifier>EISSN: 2326-5205</identifier><identifier>DOI: 10.1002/art.34373</identifier><identifier>PMID: 22231288</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Antirheumatic Agents - therapeutic use ; Arthritis ; Arthritis, Juvenile - diagnosis ; Arthritis, Juvenile - drug therapy ; Arthritis, Juvenile - pathology ; Biological and medical sciences ; Child ; Diseases of the osteoarticular system ; Female ; Humans ; Inflammatory joint diseases ; Joints - pathology ; Male ; Medical research ; Medical sciences ; Methotrexate - therapeutic use ; Parents &amp; parenting ; Reproducibility of Results ; Sensitivity and Specificity ; Severity of Illness Index ; Surveys and Questionnaires ; Treatment Outcome</subject><ispartof>Arthritis &amp; rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2366-2374</ispartof><rights>Copyright © 2012 by the American College of Rheumatology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 by the American College of Rheumatology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</citedby><cites>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.34373$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.34373$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26177050$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22231288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Consolaro, Alessandro</creatorcontrib><creatorcontrib>Bracciolini, Giulia</creatorcontrib><creatorcontrib>Ruperto, Nicolino</creatorcontrib><creatorcontrib>Pistorio, Angela</creatorcontrib><creatorcontrib>Magni-Manzoni, Silvia</creatorcontrib><creatorcontrib>Malattia, Clara</creatorcontrib><creatorcontrib>Pederzoli, Silvia</creatorcontrib><creatorcontrib>Davì, Sergio</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Ravelli, Angelo</creatorcontrib><creatorcontrib>Paediatric Rheumatology International Trials Organization</creatorcontrib><creatorcontrib>for the Paediatric Rheumatology International Trials Organization</creatorcontrib><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><title>Arthritis &amp; rheumatology (Hoboken, N.J.)</title><addtitle>Arthritis &amp; Rheumatism</addtitle><description>Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity. Results With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values. Conclusion Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</description><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - diagnosis</subject><subject>Arthritis, Juvenile - drug therapy</subject><subject>Arthritis, Juvenile - pathology</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Joints - pathology</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Parents &amp; parenting</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><issn>0004-3591</issn><issn>2326-5191</issn><issn>1529-0131</issn><issn>2326-5205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kd1u1DAQhS0EokvhghdAlhASSE3rnzhOuKtaKD8VSKVQxI1lOxPW28QJtrew78RDYtjtVgJxZY39nTPHMwg9pGSfEsIOdEj7vOSS30IzKlhTEMrpbTQjhJQFFw3dQfdiXOSSccHvoh3GGKesrmfo5xkMLkY3-j08OO8G3ePWRdARsLbJXbm02sPat7myMCVtesBxNUxpHHBMOgF2Hi-WV-BdfnGtGyed5s7iHGoeXHLxOT6GLlv7r9jmCwhOY5P9Wzx6nOZwo95K_omAox0D3Ed3Ot1HeLA5d9HHly_Oj14Vp-9PXh8dnha2FBUvKqNNzY0UUlMrTdUZQkQp2rqrDLTUdBYsa0Rjm7Yuy5ZpRqvaGs4pKamsDd9FT9e-Uxi_LSEmlWdkoe-1h3EZFSWM1bypZZnRx3-hi3EZfE6nqKCSUllVNFPP1pQNY4wBOjWFPOqwylbq9wpV_rr6s8LMPto4Ls0A7Za83lkGnmwAHa3uu6C9dfGGq6iURJDMHay573m2q_93VIdn59eti7XCxQQ_tgodLlUluRTq4t2J-nLxtv7w5vMndcx_AdzgxVM</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Consolaro, Alessandro</creator><creator>Bracciolini, Giulia</creator><creator>Ruperto, Nicolino</creator><creator>Pistorio, Angela</creator><creator>Magni-Manzoni, Silvia</creator><creator>Malattia, Clara</creator><creator>Pederzoli, Silvia</creator><creator>Davì, Sergio</creator><creator>Martini, Alberto</creator><creator>Ravelli, Angelo</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201207</creationdate><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><author>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - diagnosis</topic><topic>Arthritis, Juvenile - drug therapy</topic><topic>Arthritis, Juvenile - pathology</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Joints - pathology</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Parents &amp; parenting</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Consolaro, Alessandro</creatorcontrib><creatorcontrib>Bracciolini, Giulia</creatorcontrib><creatorcontrib>Ruperto, Nicolino</creatorcontrib><creatorcontrib>Pistorio, Angela</creatorcontrib><creatorcontrib>Magni-Manzoni, Silvia</creatorcontrib><creatorcontrib>Malattia, Clara</creatorcontrib><creatorcontrib>Pederzoli, Silvia</creatorcontrib><creatorcontrib>Davì, Sergio</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Ravelli, Angelo</creatorcontrib><creatorcontrib>Paediatric Rheumatology International Trials Organization</creatorcontrib><creatorcontrib>for the Paediatric Rheumatology International Trials Organization</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Consolaro, Alessandro</au><au>Bracciolini, Giulia</au><au>Ruperto, Nicolino</au><au>Pistorio, Angela</au><au>Magni-Manzoni, Silvia</au><au>Malattia, Clara</au><au>Pederzoli, Silvia</au><au>Davì, Sergio</au><au>Martini, Alberto</au><au>Ravelli, Angelo</au><aucorp>Paediatric Rheumatology International Trials Organization</aucorp><aucorp>for the Paediatric Rheumatology International Trials Organization</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</atitle><jtitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</jtitle><addtitle>Arthritis &amp; Rheumatism</addtitle><date>2012-07</date><risdate>2012</risdate><volume>64</volume><issue>7</issue><spage>2366</spage><epage>2374</epage><pages>2366-2374</pages><issn>0004-3591</issn><issn>2326-5191</issn><eissn>1529-0131</eissn><eissn>2326-5205</eissn><coden>ARHEAW</coden><abstract>Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity. Results With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values. Conclusion Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22231288</pmid><doi>10.1002/art.34373</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-3591
ispartof Arthritis & rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2366-2374
issn 0004-3591
2326-5191
1529-0131
2326-5205
language eng
recordid cdi_proquest_miscellaneous_1022839874
source MEDLINE; Wiley Online Library All Journals
subjects Antirheumatic Agents - therapeutic use
Arthritis
Arthritis, Juvenile - diagnosis
Arthritis, Juvenile - drug therapy
Arthritis, Juvenile - pathology
Biological and medical sciences
Child
Diseases of the osteoarticular system
Female
Humans
Inflammatory joint diseases
Joints - pathology
Male
Medical research
Medical sciences
Methotrexate - therapeutic use
Parents & parenting
Reproducibility of Results
Sensitivity and Specificity
Severity of Illness Index
Surveys and Questionnaires
Treatment Outcome
title Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Remission,%20minimal%20disease%20activity,%20and%20acceptable%20symptom%20state%20in%20juvenile%20idiopathic%20arthritis:%20Defining%20criteria%20based%20on%20the%20juvenile%20arthritis%20disease%20activity%20score&rft.jtitle=Arthritis%20&%20rheumatology%20(Hoboken,%20N.J.)&rft.au=Consolaro,%20Alessandro&rft.aucorp=Paediatric%20Rheumatology%20International%20Trials%20Organization&rft.date=2012-07&rft.volume=64&rft.issue=7&rft.spage=2366&rft.epage=2374&rft.pages=2366-2374&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.34373&rft_dat=%3Cproquest_cross%3E3277941431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1517117661&rft_id=info:pmid/22231288&rfr_iscdi=true